Use of LTB4 antagonists in veterinary medicine

Details Use of LTB4 antagonists in veterinary medicine Use of LTB4 antagonists in veterinary medicine

2005-07-26

2005-07-26

Price, Elvis O. (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S637000, C536S004100, C564S244000

Reexamination Certificate

active

06921752

ABSTRACT:
The invention relates to the use of LTB4antagonists for preparing a pharmaceutical composition for the treatment or prevention of respiratory diseases in companion and domesticated animals.

REFERENCES:
patent: 5246965 (1993-09-01), Main
patent: 5366982 (1994-11-01), Dereu et al.
patent: 6197824 (2001-03-01), Schromm et al.
patent: 6265612 (2001-07-01), Schromm et al.
patent: 6291531 (2001-09-01), Anderskewitz
patent: 0 544 488 (1993-02-01), None
Fink, Mitchell P. et al.: “A novel leukotriene B-4-receptor antagonist in endotoxin shock: A prospective, controlled trial in a porcine model.” Critical Care Medicine, vol. 21, No. 12, 1993, pp. 1825-1837.
W.H.M. Stevens et al., “Effect of a Leukotriene B4 Receptor Antagonist SC-53228 on Ozone-Induced Airway Hyperresponsiveness and Inflamation in Dogs.” Am. J. Resp. Crit. Care Med., vol. 152, pp. 1443-1448, 1995.

Affiliated with

Also associated with

Rating

Use of LTB4 antagonists in veterinary medicine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of LTB4 antagonists in veterinary medicine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of LTB4 antagonists in veterinary medicine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3409800